HER-2/neu gene copy number quantified by real-time PCR: Comparison of gene amplification, heterozygosity, and immunohistochemical status in breast cancer tissue

Clinical Chemistry

Volumn 49, Issue 2, 2003, Pages 219-229

  Königshoff, Melanie ^a   Wilhelm, Jochen ^a   Bohle, Rainer M ^a   Pingoud, Alfred ^a   Hahn, Meinhard ^a,b  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALLELE; ARTICLE; BREAST CANCER; CAPILLARY ELECTROPHORESIS; DIAGNOSTIC ACCURACY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE OVEREXPRESSION; HETEROZYGOSITY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; ONCOGENE NEU; PATHOGENESIS; POLYMERASE CHAIN REACTION; PROGNOSIS; SIMULATION;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; FEMALE; GENE DOSAGE; HETEROZYGOTE; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; POLYMERASE CHAIN REACTION; RECEPTOR, ERBB-2;

EID: 0037306910     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/49.2.219     Document Type: Article

References (38)

1. Yarden Y, Sliwkowski MX. Untangling the ErbB signalling network [Review]. Nat Rev Mol Cell Biol 2001;2:127-37.
2. Meric F, Hung MC, Hortobagyi GN, Hunt KK. HER2/neu in the management of invasive breast cancer [Review]. J Am Coll Surg 2002;194:488-501.
3. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 1987;235:177-82.
4. Muss HB, Thor AD, Berry DA, Kute T, Liu ET, Koerner F, et al. c-erbB-2 expression and response to adjuvant therapy in women with node-positive early breast cancer. N Engl J Med 1994;330:1260-6.
5. Baselga J, Norton L, Albanell J, Kim YM, Mendelsohn J. Recombinant humanized anti-HER2 antibody (Herceptin) enhances the antitumor activity of paclitaxel and doxorubicin against HER2/neu overexpressing human breast cancer xenografts. Cancer Res 1998;58:2825-31.
6. Baselga J, Tripathy D, Mendelsohn J, Baughman S, Benz CC, Dantis L, et al. Phase II study of weekly intravenous trastuzumab (Herceptin) in patients with HER2/neu-overexpressing metastatic breast cancer. Semin Oncol 1999;26(4 Suppl 12):78-83.
7. Roche PC, Ingle JN. Increased HER2 with U. S. Food and Drug Administration-approved antibody. J Clin Oncol 1999;17:434-5.
8. Pauletti G, Godolphin W, Press MF, Slamon DJ. Detection and quantification of HER-2/neu gene amplification in human breast cancer archival material using fluorescence in situ hybridization. Oncogene 1996;13:63-72.
9. Okuyama N, Hatano Y, Park, Y, Shimatani S, Sasamoto S, Katou N, et al. Quantification of c-erbB-2 gene amplification in breast cancer tissue by competitive PCR. Tumor Biol 1999;20:153-61.
10. Revillion F, Hornez L, Peyrat JP. Quantification of c-erbB-2 gene expression in breast cancer by competitive RT-PCR. Clin Chem 1997;43:2114-20.
11. Specht K, Richter T, Müller U, Walch A, Werner M, Hofler H. Quantitative gene expression analysis in microdissected archival formalin-fixed and paraffin-embedded tumor tissue. Am J Pathol 2001;158:419-29.
12. Bieche I, Onody P, Laurendeau I, Olivi M, Vidaud D, Lidereau R, et al. Real-time reverse transcription-PCR assay for future management of ERBB2-based clinical applications. Clin Chem 1999;45:1148-56.
13. Lyon E, Millson A, Lowery MC, Woods R, Wittwer CT. Quantification of HER2/neu gene amplification by competitive PCR using fluorescent melting curve analysis. Clin Chem 2001;47:844-51.
14. Lehmann U, Glöckner S, Kleeberger W, von Wasielewski HF, Kreipe H. Detection of gene amplification in archival breast cancer specimens by laser-assisted microdissection and quantitative real-time polymerase chain reaction. Am J Pathol 2000;156:1855-64.
15. Bieche I, Olivi M, Champeme MH, Vidaud D, Lidereau R, Vidaud M. Novel approach to quantitative polymerase chain reaction using real-time detection: application to the detection of gene amplification in breast cancer. Int J Cancer 1998;78:661-6.
16. Wilhelm J, Hahn M, Pingoud A. Influence of DNA target melting behavior on real-time PCR quantification. Clin Chem 2000;46:1738-43.
17. Meuer S, Wittwer C, Nakagawara KI, eds. Rapid cycle real time PCR: methods and applications. Berlin: Springer Verlag, 2001: 419 pp.
18. Wilhelm J, Pingoud A, Hahn M. Detection of p53 allele deletions in human cancer by quantification of genomic copy number. In: Meuer S, Wittwer C, Nakagawara KI, eds. Rapid cycle real time PCR: methods and applications. Berlin: Springer Verlag, 2001:159-70.
19. Higuchi R, Dollinger G, Walsh PS, Griffith R. Simultaneous amplification and detection of specific DNA sequences. Biotechnology 1992;10:413-7.
20. Wittwer CT, Herrmann MG, Moss AA, Rasmussen RP. Continuous fluorescence monitoring of rapid cycle DNA amplification. Biotechniques 1997;22:130-8.
21. Manly B. Randomization, bootstrap & Monte Carlo methods in biology. London: Chapman & Hall, 1997: 399 pp.
22. Brownstein MJ, Carpten JD, Smith JR. Modulation of non-templated nucleotide addition by Taq DNA polymerase: primer modifications that facilitate genotyping. Biotechniques 1996;20:1004-10.
23. Hahn M, Wilhelm J, Pingoud A. Influence of fluorophor dye labels on the migration behavior of polymerase chain reaction-amplified short tandem repeats during denaturing capillary electrophoresis. Electrophoresis 2001;22:2691-700.
24. Hahn M, Matzen SE, Serth J, Pingoud, A. Semiautomated quantitative detection of loss of heterozygosity in tumor suppressor gene p53. Biotechniques 1995;18:1040-7.
25. Roetger A, Brandt B, Barnekow A. Competitive-differential polymerase chain reaction for gene dosage estimation of erbB-1 (egfr), erbB-2, and erbB-3 oncogenes. DNA Cell Biol 1997;16:443-8.
26. Hynes NE, Gerber HA, Saurer S, Groner B. Overexpression of the c-erbB-2 protein in human breast tumor cell lines. J Cell Biochem 1989;39:167-73.
27. Kraus MH, Popescu NC, Amsbaugh SC, King CR. Overexpression of the EGF receptor-related proto-oncogene erbB-2 in human mammary cell lines by different molecular mechanisms. EMBO J 1987;6:605-10.
28. Frye RA, Benz CC, Liu E. Detection of amplified oncogenes by differential polymerase chain reaction. Oncogene 1989;4:1153-7.
29. Freeman WM, Walker SJ, Vrana KE. Quantitative RT-PCR: pitfalls and potential. Biotechniques 1999;26:112-22,124-5.
30. Bankfalvi A, Simon R, Brandt B, Burger H, Vollmer I, Dockhorn-Dworniczak B, et al. Comparative methodological analysis of erbB-2/HER-2 gene dosage, chromosomal copy number and protein overexpression in breast carcinoma tissues for diagnostic use. Histopathology 2000;37:411-9.
31. Heid CA, Stevens J, Livak KJ, Williams PM. Real time quantitative PCR. Genome Res 1996;6:986-94.
32. Mitelman F, Johansson B, Mertens F, eds. Mitelman database of chromosome aberrations in cancer. http://cgap.nci.nih.gov/Chromosomes/Mitelman (accessed September 30, 2002).
33. Lyon E, Millson A, Suli A. HER/neu gene amplification quantified by PCR and melting peak analysis using a single base alteration competitor as an internal standard. In: Meuer S, Wittwer C, Nakagawara KI, eds. Rapid cycle real time PCR: methods and applications. Berlin: Springer Verlag, 2001:207-17.
34. Woods R. Relative quantification of the HER2/neu oncogene using SYBR green I. In: Meuer S, Wittwer C, Nakagawara KI, eds. Rapid cycle real time PCR: methods and applications. Berlin: Springer Verlag, 2001:241-8.
35. Somerville JE, Clarke LA, Biggart JD. C-erbB-2 overexpression and histological type of in situ and invasive breast carcinoma. J Clin Pathol 1992;45:16-20.
36. Heatley M, Maxwell P, Whiteside C, Toner PG. C-erbB-2 oncogene product expression depends on tumor type and is related to oestrogen receptor and lymph node status in human breast carcinoma. Pathol Res Pract 1993;189:261-6.
37. Revillion F, Bonneterre J, Peyrat JP. ERBB2 oncogene in human breast cancer and its clinical significance [Review]. Eur J Cancer 1998;34:791-808.
38. Wilhelm J, Pingoud A, Hahn M. Comparison between Taq DNA polymerase and its Stoffel fragment for quantitative real-time PCR with hybridization probes. Biotechniques 2001;30:1052-62.